A Study to Assess the Role of a Gluten Free-dairy Free (GFCF) Diet in the Dietary Management of Autism Associated Gastrointestinal Disorders

Completed · Not applicable

Conditions studied: Autism, Gastrointestinal Symptoms

In brief

Doctors at MassGeneral Hospital for Children (MGHfC) are doing a research study to learn if a gluten free-dairy free (GFCF) diet is helpful in improving gastrointestinal symptoms associated with autism. Hypothesis: The gluten free/casein free diet (GFCF) will result in a higher proportion of subjects having reduction in gastrointestinal (GI) symptoms associated with autism spectrum disorders (ASD). Primary Study Objective: * To assess the effect of a GFCF diet on GI symptoms associated with ASD. Secondary Objectives: * To assess if improvements in GI symptoms result in improvements in autistic behavior when using a GFCF diet in the dietary management of GI symptoms associated with ASD * To determine the nutritional impact of a GFCF restrictive diet * To assess the role of food allergies in the manifestation of GI symptoms This is a 14-week study that requires between 5 \& 9 office visits. All study related activities -including physical exams, blood samples and allergy testing - and an amino acid based supplement drink, are at no cost. Research study visits will take place at MGHfC in Boston, or at Newton Wellesley Hospital in Newton, or at Lurie Center/LADDERS in Lexington.

Key facts

Study ID: NCT01116388
Run by: Massachusetts General Hospital
People needed: 65
Starts: 2010-04-01
Expected to finish: 2015-04-01
Last updated by the study team: 2015-04-08

Who can join

Age: 2 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Informed consent / Assent, as applicable must be signed prior to executing any study related procedure
Children, male or female, 2 to 17 years old (inclusive)
Confirmed diagnosis of ASD according to the diagnostic measures:
DSM-IV Symptom Checklist
Autism Diagnostic Observation Schedule(ADOS)\&/or Autism Diagnostic Interview Revised(ADI-R)within 18 months prior to entry into the study
Subjects must present with a current history of at least two of the following persistent GI symptoms as confirmed by the study physician:
Diarrhea, as characterised by three or more loose stools a day for at least 8 out of 14 days
Constipation as characterised by less than 3 bowel movements per week, for at least a 2-week period
Esophageal reflux, as characterised by 3 or more episodes of regurgitation per day on 10 out of 14 days
Abdominal pain manifested as pain after eating or self injurious behavior on at least 8 out of 14 days
Suspected food allergy which is confirmed by a physician, as characterized as a recurrent reaction or association with specific foods
Subject able to consume 3 tablespoons of study powder mixed in food daily for 12 weeks

You may not qualify if…

Children with a history of anaphylaxis to dietary milk and wheat proteins
Children with severe concurrent illness
Children who are prescribed systemic steroids
Children currently receiving chelation therapy, hyperbaric or antifungal treatment within 1 month of entry into the study and during the study period.
Children with a confirmed diagnosis of celiac disease
Subjects who have previously tried dietary elimination of casein and gluten for at least 1 month period and failed to demonstrate a response by parent perception
Children who are unable to consume 3 tablespoons of study powder mixed in food daily for 12 weeks daily

Where it is running

Massachusetts General Hospital — Boston, Massachusetts, United States
Baylor College of Medicine / Texas Children's Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.